Literature DB >> 14507881

Ag-specific recognition, activation, and effector function of T cells in the conjunctiva with experimental immune-mediated blepharoconjunctivitis.

Atsuki Fukushima1, Akemi Ozaki, Kazuyo Fukata, Waka Ishida, Hisayuki Ueno.   

Abstract

PURPOSE: To investigate antigen (Ag) specificity, activation, and effector function of the Ag-specific T cells involved in the development of experimental immune-mediated blepharoconjunctivitis (EC), an experimental conjunctivitis.
METHODS: EC was induced in Brown Norway rats by injection of ovalbumin (OVA)-specific T cells followed by OVA challenge with eye drops. Eyes, including the conjunctivas, were harvested at different time points after challenge. The dependence of EC onset on the challenging Ag was assessed by challenge with an irrelevant Ag or stimulatory OVA peptides. To show the infiltration of transferred T cells into the conjunctiva, T cells were labeled with 5-(and-6)-carboxyfluorescein diacetate succinimidyl ester (CFSE) before transfer. The activation of T cells in the conjunctiva was assessed by measuring phosphorylation of Lck-associated molecules by Western blot analysis. Conjunctivas were also examined by immunohistochemistry and used for reverse transcription-polymerase chain reaction to determine the phenotype of the infiltrating cells and cytokine, chemokine, and chemokine receptor expression. To investigate infiltration of non Ag-specific T cells into the conjunctiva, ragweed (RW)-primed lymphocytes were transferred into OVA-specific T-cell receptor transgenic (DO11.10) mice. The mice were then challenged with RW and the conjunctivas were harvested for immunohistochemistry to detect T cells derived from DO11.10 mice.
RESULTS: EC was induced only when challenged with OVA protein or stimulatory OVA peptides, and CFSE-labeled transferred cells were found in the conjunctiva. Phosphorylation of Lck and an 85-kDa Lck-associated molecule were observed in the conjunctiva 6 hours after challenge. Many cytokines and chemokines began to be expressed at 6 hours, and individual expression patterns over time correlated well with the infiltration patterns of different inflammatory cells. In DO11.10 mice that received RW-primed lymphocytes, T cells derived from the recipient mice infiltrated the conjunctiva after RW challenge.
CONCLUSIONS: Ag-specific T cells initiate EC by first infiltrating the conjunctiva, where they become activated by the specific Ag in the conjunctiva.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14507881     DOI: 10.1167/iovs.02-1323

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  13 in total

1.  Temporal protein expression pattern in intracellular signalling cascade during T-cell activation: a computational study.

Authors:  Piyali Ganguli; Saikat Chowdhury; Rupa Bhowmick; Ram Rup Sarkar
Journal:  J Biosci       Date:  2015-10       Impact factor: 1.826

2.  Interleukin 10 and transforming growth factor beta contribute to the development of experimentally induced allergic conjunctivitis in mice during the effector phase.

Authors:  A Fukushima; T Sumi; K Fukuda; N Kumagai; T Nishida; H Yagita; H Ueno
Journal:  Br J Ophthalmol       Date:  2006-08-16       Impact factor: 4.638

3.  Aggravation of conjunctival early-phase reaction by Staphylococcus enterotoxin B via augmentation of IgE production.

Authors:  Dai Miyazaki; Waka Ishida; Takeshi Tominaga; Tamaki Sumi; Atsuki Fukushima
Journal:  Jpn J Ophthalmol       Date:  2010-11-05       Impact factor: 2.447

4.  Secondary allergic T cell responses are regulated by dendritic cell-derived thrombospondin-1 in the setting of allergic eye disease.

Authors:  R E Smith; N J Reyes; P Khandelwal; S L Schlereth; H S Lee; S Masli; D R Saban
Journal:  J Leukoc Biol       Date:  2016-02-08       Impact factor: 4.962

5.  Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice.

Authors:  A Fukushima; T Yamaguchi; M Azuma; H Yagita; H Ueno
Journal:  Br J Ophthalmol       Date:  2006-04-13       Impact factor: 4.638

Review 6.  Immune regulatory mechanisms in allergic conjunctivitis: insights from mouse models.

Authors:  Jerry Y Niederkorn
Journal:  Curr Opin Allergy Clin Immunol       Date:  2008-10

7.  Antibody array-generated cytokine profiles of tears of patients with vernal keratoconjunctivitis or giant papillary conjunctivitis.

Authors:  Jun Shoji; Noriko Inada; Mitsuru Sawa
Journal:  Jpn J Ophthalmol       Date:  2006 May-Jun       Impact factor: 2.211

8.  Roles of CD4+CD25+ T cells in the development of experimental murine allergic conjunctivitis.

Authors:  Atsuki Fukushima; Tomoko Yamaguchi; Tamaki Sumi; Ken Fukuda; Naoki Kumagai; Teruo Nishida; Masaru Takeuchi; Osamu Taguchi; Hisayuki Ueno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-10-06       Impact factor: 3.535

9.  Levocetirizine inhibits migration of immune cells to lymph nodes and induces treg cells in a murine type I allergic conjunctivitis model.

Authors:  Sihomara García-Zepeda; Elizabet Estrada-Muñiz; Guillermo Elizondo; Luis I Terrazas; Miriam Rodríguez-Sosa; Juan D Quintana-Hau; Rubén Tornero-Montaño; Leopoldo Baiza-Durán; Libia Vega
Journal:  Open Ophthalmol J       Date:  2012-12-14

10.  Topical cyclosporin as an alternative treatment for vision threatening blepharokeratoconjunctivitis: a case report.

Authors:  Abdul-Salim Ismail; Rohana Taharin; Zunaina Embong
Journal:  Int Med Case Rep J       Date:  2012-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.